Radebeul, Germany

Thomas Arnold


Average Co-Inventor Count = 6.6

ph-index = 1


Company Filing History:


Years Active: 2000-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas Arnold: Innovator in Antiepileptic Compounds

Introduction

Thomas Arnold is a notable inventor based in Radebeul, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiepileptic compounds. With a total of 3 patents to his name, Arnold's work has the potential to impact the treatment of various neurological conditions.

Latest Patents

Arnold's latest patents include innovative compounds such as 4-amino-1-aryl-1,5-dihydropyrrol-2-ones and 4-amino-1-arylpyridin-2-ones. The first patent relates to a process for making 1,5-dihydropyrrol-2-ones, which contain an aryl radical in the 1-position and a secondary amine radical in the 4-position. This invention is particularly relevant for treating various forms of epilepsies and states of anxiety and tension. The second patent focuses on antiepileptic compounds that can be used as anticonvulsives, showcasing Arnold's commitment to addressing critical health issues.

Career Highlights

Arnold is currently associated with Arzneimittelwerk Dresden GmbH, where he continues to innovate in the pharmaceutical sector. His work is characterized by a strong focus on developing effective treatments for epilepsy and related disorders.

Collaborations

Arnold has collaborated with notable colleagues such as Klaus Unverferth and Hans-Joachim Lankau. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Thomas Arnold is a distinguished inventor whose work in antiepileptic compounds has the potential to make a significant impact on the treatment of neurological disorders. His innovative patents and collaborations reflect his dedication to improving patient outcomes in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…